Novel composition

Details for Australian Patent Application No. 2006226458 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Stephenne, Jean; Hanon, Emmanuel Jules

Agent Shelston IP

Pub. Number AU-B-2006226458

PCT Pub. Number WO2006/100110

Priority 0506004.1 23.03.05 GB; 0506000.9 23.03.05 GB; 0603790.7 24.02.06 GB; 0510596.0 24.05.05 GB; 0510593.7 24.05.05 GB; 0505998.5 23.03.05 GB; 0510591.1 24.05.05 GB; 0603788.1 24.02.06 GB; 0510589.5 24.05.05 GB; 0510598.6 24.05.05 GB; 0506001.7 23.03.05 GB; 0505989.4 23.03.05 GB; 0603789.9 24.02.06 GB

Filing date 21 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 30 August 2012

International Classifications

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/145 Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100110 Priority application(s): WO2006/100110

30 August 2012 Application Accepted

  Published as AU-B-2006226458

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226459-Composition

2006226450-Optimum selection of a communication network in the location area of a terminal